Hurdles on the road to personalized medicine.


Cancer treatment is slowly shifting from an approach in which the tissue of origin and the histology were the guiding principles for the choice of chemotherapy towards a genotype-centric approach in which the changes in the cancer genome are used to select patients for treatment with highly selective and targeted drugs. This transition has all the hallmarks of a disruptive innovation and requires major adjustments in the way that cancer is diagnosed and treated. We discuss here the hurdles on the road ahead to a more personalized treatment of cancer.

DOI: 10.1016/j.molonc.2014.08.009
Citations per Year

Citation Velocity: 15

Averaging 15 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Tursz2015HurdlesOT, title={Hurdles on the road to personalized medicine.}, author={Thomas Tursz and Rene Bernards}, journal={Molecular oncology}, year={2015}, volume={9 5}, pages={935-9} }